MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Aug 2024 Evaluate
The sales for the June 2024 quarter moved up 39.82% to Rs. 2545.27 millions as compared to Rs. 1820.41 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 320.15  millions from Rs. 441.91 millions ,decline by -27.55%.A decline of 494.18 millions was observed in the OP in the quarter ended June 2024 from 593.81 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2545.27 1820.41 39.82 2545.27 1820.41 39.82 8532.73 6552.04 30.23
Other Income 81.52 326.23 -75.01 81.52 326.23 -75.01 620.73 604.82 2.63
PBIDT 494.18 593.81 -16.78 494.18 593.81 -16.78 2020.08 1523.85 32.56
Interest 2.83 2.62 8.02 2.83 2.62 8.02 9.88 36.13 -72.65
PBDT 491.35 591.19 -16.89 491.35 591.19 -16.89 2010.20 1487.72 35.12
Depreciation 68.36 47.24 44.71 68.36 47.24 44.71 291.28 167.37 74.03
PBT 422.99 543.95 -22.24 422.99 543.95 -22.24 1718.92 1320.35 30.19
TAX 102.84 102.04 0.78 102.84 102.04 0.78 381.34 291.69 30.73
Deferred Tax -0.74 26.94 -102.75 -0.74 26.94 -102.75 6.78 -1.71 -496.49
PAT 320.15 441.91 -27.55 320.15 441.91 -27.55 1337.58 1028.66 30.03
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 45316.00 -99.00
PBIDTM(%) 19.42 32.62 -40.48 19.42 32.62 -40.48 23.67 23.26 1.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..